ArticleFrontiers in immunology2022

Immune-related RNA signature predicts outcome of PD-1 inhibitor-combined GEMCIS therapy in advanced intrahepatic cholangiocarcinoma.

Tian-Mei Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.